India to United States: Adaptogen Export Trade Route
India has recorded 11 verified shipments of Adaptogen exported to United States, representing a combined trade value of $5.5K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $502 USD. The leading Indian exporter is KERALA AYURVEDA LIMITED, which accounts for 100% of total export value with 11 shipments worth $5.5K USD. On the buying side, SUVEDA INC.D/B/A KERALA AYURVEDA is the largest importer in United States with $2.9K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Adaptogen corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $5.5K USD. The route is dominated by KERALA AYURVEDA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's adaptogen manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $502 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with adaptogen's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #1 among India's top adaptogen export destinations globally.
On the import side, key buyers of Indian adaptogen in United States include SUVEDA INC.D/B/A KERALA AYURVEDA, SUVEDA INC, SUVEDA INC D B A KERALA and 1 others. SUVEDA INC.D/B/A KERALA AYURVEDA is the single largest importer with 7 shipments valued at $2.9K USD.
